Mesalazine also known as mesalamine or 5-aminosalicylic acid is an anti-inflammatory drug used to treat inflammatory bowel disease, such as ulcerative colitis and mild-to-moderate Crohn's disease. This drug is a bowel-specific aminosalicylate drug that acts locally in the gut and has its predominant actions there, thereby having few systemic side effects. Pentasa is mesalazine formulated as an oral capsule.
Mesalazine is used for management of ulcerative colitis (as oral delayed-release tablets or extended-release capsules) and to induce (as extended-release capsules and as 1.2-g delayed-release tablets) and maintain (as 400-mg delayed-release tablets) clinical remission in adults with mildly to moderately active disease.
Mesalazine has been used (as extended-release oral preparations) for the management of active Crohn’s disease and to induce and maintain clinical remission in adults with mildly to moderately active disease.
Information from Drugs.com
Next medication people use after Pentasa
Current Users' Health
Compared to people not currently on Pentasa
The data on this page is from personally submitted user reviews and ratings of treatments, and users who have tracked their health over time while taking these treatments. The data is of a small sample size of users and is subject to biases of side effects of treatments, perceived/expected efficacy, and more. For now, the data should be taken with a grain of salt.